Timothy Illidge, MD, PhD, Professor of Targeted Therapy and Oncology, Division of Cancer Sciences, The Christie Hospital, @OfficialUoM shares the the primary and secondary endpoints of the ECHELON-2 study.
ECHELON-2 Study Endpoints @OfficialUoM
Timothy Illidge, MD, PhD, Professor of Targeted Therapy and Oncology, Division of Cancer Sciences, The Christie Hospital, @OfficialUoM shares the the primary and secondary endpoints of the ECHELON-2 study.